Co-Diagnostics, Inc. Common Stock (CODX) Stock Forecast & Price Target
Co-Diagnostics, Inc. Common Stock · NASDAQ
$1.25+0.03 (+2.03%)
15-min delayed · Aug 26, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Co-Diagnostics, Inc. Common Stock, 1 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $1.50 to $3.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $2.25 sits 79% above the current $1.25. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.27 next quarter toward $-0.83 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy133%
Hold267%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Co-Diagnostics, Inc. Common Stock.
As of Aug, 1 of 3 firms rate CODX a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CODX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.27
Range $-0.27 – $-0.27 · 1 analysts · -94% YoY
Next period, 1 analysts expect Co-Diagnostics, Inc. Common Stock to earn $-0.27 a share (range $-0.27 – $-0.27), versus $-4.44 a year earlier. Full-year consensus is $-3.10, growing to $-0.83 the year after.
REVENUE · NEXT QUARTER
$173.0K
Range $173.0K – $173.0K · 1 analysts · -34% YoY
Revenue is expected to reach $173.0K (range $173.0K – $173.0K), -34.4% year-over-year. Full-year consensus is $654.0K, rising to $17.3M next year.
Top analysts covering Co-Diagnostics, Inc. Common Stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CODX.
#1
Yi Chen
HC Wainwright & Co. · Rank #276
Hold
No targeton CODX
Overall win rate
33%
+ Follow
#2
Jason Kolbert
D. Boral Capital · Rank #407
Buy
$3.00+139.0% to target
Overall win rate
22%
+ Follow
#3
Jason McCarthy
Maxim Group · Rank #417
Hold
No targeton CODX
Overall win rate
33%
+ Follow
CODX stock forecast FAQ
What is CODX's average 12-month price target?+
The 1 analysts with a live target average $2.25 for Co-Diagnostics, Inc. Common Stock over the next 12 months, ranging from a $3.00 high to a $1.50 low.
Is CODX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 1 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CODX?+
The Street-high target is $3.00 (D. Boral Capital), and the Street-low is $1.50. The average of all 1 active targets is $2.25.
How many Wall Street analysts cover CODX?+
3 analysts have an active rating on Co-Diagnostics, Inc. Common Stock, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering CODX?+
Among analysts who currently cover CODX, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #276). Their current call is Hold.
What is Co-Diagnostics, Inc. Common Stock's projected EPS for next quarter?+
The consensus estimate is $-0.27 per share (range $-0.27 – $-0.27) across 1 analysts. Full-year EPS is projected at $-3.10, rising to $-0.83 the following year.
How much revenue is Co-Diagnostics, Inc. Common Stock expected to report next quarter?+
Consensus revenue is $173.0K (range $173.0K – $173.0K). Full-year revenue is projected at $654.0K, growing to $17.3M next year.
Have analysts been upgrading or downgrading CODX lately?+
As of Aug, 1 of 3 firms rate CODX a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CODX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
